Resumen
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.
Idioma original | Inglés estadounidense |
---|---|
Páginas (desde-hasta) | 3011-3022 |
- | 12 |
Publicación | Human Vaccines and Immunotherapeutics |
Volumen | 16 |
N.º | 12 |
DOI | |
Estado | Indizado - 2020 |
Publicado de forma externa | Sí |
Nota bibliográfica
Publisher Copyright:© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.